Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey R Oxnard

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Cancers|July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical PracticeLincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.
Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate EvaluationMichael L Maitland, Julia Wilkerson, Sanja Karovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfoundKim N Chi, Alan Barnicle, Caroline Sibilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung CancersJulia Rotow, Jyoti D Patel, Matthew P Hanley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer TypesPashtoon M Kasi, Jessica K Lee, Lincoln W Pasquina, et al.
JAMA Oncology|March 17, 2022
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)Kenneth L Kehl, David Zahrieh, Ping Yang, et al.
Immunotherapy|April 21, 2021
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)Jacob M Sands, Sumithra J Mandrekar, David Kozono, et al.
JAMA Network Open|March 31, 2022
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate CancerRyon P Graf, Virginia Fisher, Janick Weberpals, et al.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor ResponseJay A Moore, Kuei-Ting Chen, Russell Madison, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Cancers|July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical PracticeLincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.
Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate EvaluationMichael L Maitland, Julia Wilkerson, Sanja Karovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfoundKim N Chi, Alan Barnicle, Caroline Sibilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung CancersJulia Rotow, Jyoti D Patel, Matthew P Hanley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer TypesPashtoon M Kasi, Jessica K Lee, Lincoln W Pasquina, et al.
JAMA Oncology|March 17, 2022
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)Kenneth L Kehl, David Zahrieh, Ping Yang, et al.
Immunotherapy|April 21, 2021
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)Jacob M Sands, Sumithra J Mandrekar, David Kozono, et al.
JAMA Network Open|March 31, 2022
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate CancerRyon P Graf, Virginia Fisher, Janick Weberpals, et al.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor ResponseJay A Moore, Kuei-Ting Chen, Russell Madison, et al.
Pageof 20